SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001126234-23-000058
Filing Date
2023-05-05
Accepted
2023-05-05 09:29:43
Documents
48
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nlnk-20230331.htm   iXBRL 10-Q 1272813
2 EX-31.1 lumo-2023331x10qxex3111.htm EX-31.1 10124
3 EX-31.2 lumo-2023331x10qxex3121.htm EX-31.2 10175
4 EX-32.1 lumo-2023331x10qxex3211.htm EX-32.1 7160
10 nlnk-20230331_g1.jpg GRAPHIC 12762
11 nlnk-20230331_g2.jpg GRAPHIC 107434
  Complete submission text file 0001126234-23-000058.txt   4547797

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20230331.xsd EX-101.SCH 24008
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20230331_cal.xml EX-101.CAL 38993
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20230331_def.xml EX-101.DEF 97420
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20230331_lab.xml EX-101.LAB 328497
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20230331_pre.xml EX-101.PRE 193346
42 EXTRACTED XBRL INSTANCE DOCUMENT nlnk-20230331_htm.xml XML 552805
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35342 | Film No.: 23891602
SIC: 2834 Pharmaceutical Preparations